-
Study aim
-
Objective: to determine the superiority of laser assisted intradiscal nucleoplasty with or without Ozone in controlling pain and disability in patients with lumbar discopathy
-
Design
-
Two arm parallel group randomized trial with blinded postoperative care and outcome assessment.
-
Settings and conduct
-
The study will be done in Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Science. After informed consent, the patients will be included in the study. The responsible doctor, operation theater staff (other than the surgeon who performs the procedure) and statistical consultant will be blind to the groups.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: radicular low back pain with evidence of discopathy/discopathies of L3-L4, L4-L5 or L5-S1 in MRI in patients who fail to respond to conservative therapy and peri-root therapy.
Exclusion criteria: Previous back surgery, bleeding tendency, drug abuse, non-controlled psychiatric disorders, lower extremity weakness, sphincter disorder, disc protrusion more than one third of anterior-posterior spinal column diameter in MRI, disc extrusion or sequestration in MRI
-
Intervention groups
-
In both groups A and B, intradiscal nucleoplasty will be done using Diode laser PW 3.5-5 W 1200-1500 J. In group B, after completion of nucleoplasty, 2 ml of Ozone 45 mcg/ml will be injected into the disc(s).
-
Main outcome variables
-
NRS (Numerical rating scale): Simple tool that tells us the patient's perceived intensity of pain. Patients are given a scale from 0 (no pain) to 10 (worst pain).
Oswestry Disability Index (ODI) is an index derived from the Oswestry Low Back Pain Questionnaire used by clinicians and researchers to quantify disability for low back pain.